当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Satomi Konno, Takuya Kishi
In these two years, coronavirus disease 2019 (COVID-19) has come to be a global pandemic. Patients with COVID-19 often require clinical isolation for preventing the spread of infection, and clinical isolation often prevents the patients and the family to be with their loved ones when they die. Moreover, patients with heart failure are affected by COVID-19, resulting in increased mortality with a heavy burden on medical staff and healthcare resources. In this decade, palliative care has already been standard therapy for heart failure. Considering these backgrounds, palliative care should be provided to patients with heart failure and COVID-19 in the pandemic of COVID-19. Although there is no evidence showing the clinical and social benefits of palliative care for patients with heart failure and COVID-19, we summarized what is needed to provide optimal palliative and end-of-life care for patients with heart failure and COVID-19 complications in this COVID-19 pandemic and post-COVID-19 era.